Manulife Financial Corporation (NYSE:MFC) is deemed one of the most undervalued Canadian stocks to buy by hedge funds. Barclays increased its price target for MFC to C$52 from C$49, maintaining an Equal Weight rating, citing a cautiously optimistic outlook on life insurers. In Q3 2025, Manulife reported a 16% year-over-year increase in EPS and a core ROE of 18.1%, with record core earnings in its Asia, Canada, and Global WAM segments.

Despite strong performance, Manulife faced challenges in its Global WAM segment with $6.2 billion in net outflows and a 20% decrease in core earnings in the US segment due to unfavorable life insurance claims. The company also anticipates potential volatility in the Hong Kong market and a $25 million quarterly impact from regulatory changes to the Mandatory Provident Fund.

Manulife Financial Corporation (NYSE:MFC) operates internationally, providing financial products and services through its Wealth & Asset Management Businesses, Insurance & Annuity Products, and Corporate & Other segments. While MFC shows promise as an investment, some believe certain AI stocks offer greater upside potential and lower downside risk. Explore opportunities in the AI sector for potential returns.

Barclays maintains a cautiously optimistic view on Manulife Financial (MFC) despite industry challenges. The company’s performance in Q3 2025 showcased growth in core earnings across key segments, including a milestone 50:50 JV with Mahindra & Mahindra to enter the Indian life insurance market. Stay informed on developments and potential opportunities in the financial sector.

Read more at Yahoo Finance: Barclays Cautiously Optimistic On Manulife Financial (MFC) Amid Industry Challenges